BrightView Holdings, Inc.

BV

CIK 0001734713 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$615M
↑+2.6% +$16Mvs FY2024 (Q4)
Gross Profit
$114M
↓-9.9% -$13Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
35/100
  • Profitability
    0ROIC 4.5% (10% = solid, 20%+ = moat)
  • Liquidity
    40Current Ratio 1.30 (above 1.5 = solid)
  • Leverage
    69D/E 0.61 (under 0.5 = conservative)
  • Efficiency
    45Asset Turnover 0.79x (1.0+ = capital-efficient)
  • Growth
    25Revenue YoY +2.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    30Op Margin -1.2% · trend -1.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project BV's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$6.70
Total enterprise IV
$647M
Diluted shares
0.10B
Terminal PV
$469M (72% of total)
Year-5 FCF
$55M
YearProjected FCFDiscounted PV
+1$41M$37M
+2$44M$36M
+3$47M$36M
+4$51M$35M
+5$55M$34M
Terminal$755M$469M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$250M
investment in PP&E
Stock buybacks (TTM)
$38M
share count reduction
Stock-based comp (TTM)
$18M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$3.32B
everything owned
Total liabilities
$1.55B
everything owed
Stockholders' equity
$1.25B
shareholder claim
Net debt
$764M
LT debt minus cash

Recent performance · 35 quarters

Revenue↑+2.6% +$16M
$615M
Net Income↓-46.2% -$5M
$-15M
Free Cash Flow↓-1133.3% -$20M
$-19M
Operating Margin↓-1.1pts
-1.2%

Drill down